Cargando…
Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation
Due to a superior dose conformity to the target, proton beam therapy (PBT) continues to rise in popularity. Recently, considerable efforts have been directed toward discovering treatment options for use in combination with PBT. This study aimed to investigate the targeting of checkpoint kinase 1 (CH...
Autores principales: | Choi, Changhoon, Cho, Won Kyung, Park, Sohee, Shin, Sung-Won, Park, Won, Kim, Haeyoung, Choi, Doo Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215565/ https://www.ncbi.nlm.nih.gov/pubmed/32294924 http://dx.doi.org/10.3390/ijms21082691 |
Ejemplares similares
-
Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation
por: Choi, Changhoon, et al.
Publicado: (2019) -
RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation
por: Badie, Sophie, et al.
Publicado: (2009) -
The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition
por: Mattiello, Luca, et al.
Publicado: (2021) -
Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC
por: Traver, Geri, et al.
Publicado: (2020) -
Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction
por: Choi, Changhoon, et al.
Publicado: (2019)